Mary Escobar
Family · Tulare, CANPI 1083238976
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,115 and has fallen 98.6% since, to $15 in 2025.
Across 130 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$470
- AbbVie$373
- Biohaven Pharmaceutical Holding Company Ltd.$251
- Biohaven Pharmaceuticals, Inc.$136
- Lilly USA, LLC$120
- GSK$104
- plus $752 from 22 others
What the payments were for
- Food & beverage$2,19399%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $470 |
| AbbVie | 24 | $373 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $251 |
| Biohaven Pharmaceuticals, Inc. | 5 | $136 |
| Lilly USA, LLC | 8 | $120 |
| GSK | 2 | $104 |
| Corcept Therapeutics | 4 | $98 |
| Viiv Healthcare Company | 1 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| AstraZeneca(2 entities) | 3 | $67 |
| Boehringer Ingelheim | 3 | $51 |
| Organon | 3 | $50 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| Mylan Specialty L.p. | 1 | $40 |
| Bayer | 2 | $34 |
| Novartis | 2 | $31 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Cranial Technologies, Inc | 1 | $18 |
| Amgen | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Chiesi USA, Inc. | 1 | $13 |
| Mayne Pharma Commercial LLC | 1 | $6 |
| Genentech USA, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$118
- Ozempic$115
- NURTEC ODT$115
How this compares
$2,205 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Other family in Tulare
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.